Skip to content
StockMarketAgent
Healthcare / Pharmaceutical RetailersUpdated 2026-05-10 22:07 UTC

SCNX stock hub

Scienture Holdings, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

SCNXis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
16.3M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
SCNX
In the news

Latest news · SCNX

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-55.6
P25 -105.6P50 -46.5P75 -3.1
ROIC-13.3
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All SCNX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
182
Groups with data
11
Currency
USD
Showing 182 of 182 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

25
MetricValue
Cik
0001382574
Company name
Scienture Holdings, Inc.
Country
United States
Country code
US
Cusip
80880X104
Employees
9
Employees Change
-10%
Employees Change Percent
-52.63
Enterprise value
$9.6M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Pharmaceutical Retailers
IPO Date
2020-02-13
Isin
US80880X1046
Last refreshed
2026-05-10
Market cap
$16.3M
Market cap category
Nano-Cap
Price
$0.4
Price currency
USD
Rev Per Employee
47,956.56x
Sector
Healthcare
Sic
2834
Symbol
SCNX
Website
https://scienture.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

5
MetricValue
Earnings Yield
-255.42%
EV/Sales
22.28x
FCF yield
-82.32%
P/B ratio
0.23x
P/S ratio
37.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

11
MetricValue
Gross margin
76.8%
Gross Profit
$331,482
Gross Profit Growth
5,420.1%
Net Income
$-41.5M
Net Income Growth Years
0%
Pretax Margin
-10,080.22%
Profit Per Employee
$-4.6M
ROA
-10.74
ROCE
-19.95
ROE
-55.65
ROIC
-13.29

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

5
MetricValue
Cagr1y
-55.59%
EPS Growth Quarters
3
EPS Growth Years
0
Revenue Growth
215.87x
Revenue Growth Years
1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

17
MetricValue
Asset Turnover
$0
Assets
$84.2M
Cash
$6.7M
Current Assets
$7.9M
Current Liabilities
$2.7M
Debt
$24,137
Debt Equity
$0
Equity
$70.1M
Interest Coverage
-3.98
Liabilities
$14.1M
Long Term Assets
$76.3M
Long Term Liabilities
$11.3M
Net Cash
$6.6M
Net Cash By Market Cap
$40.84
Net Debt Equity
$-0.09
Tangible Book Value
$-852,680
Tangible Book Value Per Share
$-0.02

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
2.89
Net Working Capital
$-1.5M
Quick ratio
2.7
Working Capital
$5.2M
Working Capital Turnover
$0.24

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-354.69%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
-55.56%
200-day SMA
0.73
50-day SMA
0.4
50-day SMA vs 200-day SMA
50under200
All Time High
13.42
All Time High Change
-97.02%
All Time High Date
2024-07-29
All Time Low
0.24
All Time Low Change
67.93%
All Time Low Date
2026-03-30
ATR
0.04
Beta1y
3.35
Beta2y
3.09
Ch YTD
-21.57
High
0.42
High52
2.6
High52 Date
2025-10-23
High52ch
-84.62%
Low
0.4
Low52
0.24
Low52 Date
2026-03-30
Low52ch
67.93%
Ma50ch
0.4%
Premarket Change Percent
-0.59
Premarket Price
$0.42
Premarket Volume
45,692
Price vs 200-day SMA
-45.06%
RSI
51.7
RSI Monthly
10.54
RSI Weekly
39.88
Sharpe ratio
0.54x
Sortino ratio
2.13
Total Return
-354.69%
Tr YTD
-21.57
Tr1m
23.84%
Tr1w
-0.3%
Tr3m
-16.25%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

7
MetricValue
Analyst Count
1
Analyst Ratings
Strong Buy
Earnings EPS Estimate
$-0.22
Operating Income
$-16.2M
Operating margin
-3,763.8
Price target
$1.5
Price Target Change
$275

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

11
MetricValue
Float
32,792,672%
Float Percent
80.71%
Net Borrowing
-6,159,444
Shares Insiders
19.29%
Shares Institutions
6.36%
Shares Out
40,630,815
Shares Qo Q
-1.99%
Shares Yo Y
354.69%
Short Float
5.25%
Short Ratio
1.94
Short Shares
4.24

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

57
MetricValue
Adjusted FCF
$-19.8M
Average Volume
505,523.55x
Bv Per Share
1.73
Ch1m
23.84
Ch1w
-0.3
Ch1y
-55.56
Ch3m
-16.25
Ch6m
-45.54
Change
-5.86%
Change From Open
-2.91
Close
0.42
Days Gap
-3.04
Depreciation Amortization
455,846
Dollar Volume
174,121.2
Earnings Date
2026-05-13
Earnings Time
amc
EBIT
$-16.2M
EBITDA
$-15.8M
EPS
$-2.7
F Score
4
FCF
$-13.4M
FCF EV Yield
-139.16x
FCF Per Share
$-0.33
Financing CF
19,733,595
Fiscal Year End
December
Founded
2,010
Income Tax
$-2M
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-03-30
Last Report Date
2025-12-31
Last Split Type
Never
Last10k Filing Date
2026-03-30
Ma150
0.54
Ma150ch
-26.14%
Ma20
0.39
Ma20ch
1.96%
Net CF
6,353,912
Next Earnings Date
2026-05-22
Open
0.41
Optionable
No
Position In Range
0
Post Close
0.4
Postmarket Change Percent
0.88
Postmarket Price
$0.4
Ppne
38,860
Pre Close
0.42
Price Date
2026-05-08
Relative Volume
0.86x
Revenue
431,609x
SBC By Revenue
1,477.95x
Share Based Comp
6,378,982
Tax By Revenue
-462.2x
Tr6m
-45.54%
Us State
New York
Volume
435,303
Z Score
-0.97
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does SCNX pay a dividend?

Capital-return profile for this ticker.

Performance

SCNX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-55.6%
S&P 500 1Y: n/a
3Y total return
n/a
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns SCNX?

Insider, institutional, and short-interest positioning.

Institutional ownership
+6.4%
Float: +80.7% of shares outstanding
Insider ownership
+19.3%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+5.3%
1.9 days to cover
Y/Y dilution
+354.7%
Negative means the company is buying back shares.
Technical

SCNX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
51.7
Neutral momentum band
Price vs 200-day MA
-45.1%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.54
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About SCNX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current SCNX stock rating?

Scienture Holdings, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full SCNX analysis?

The full report lives at /stocks/SCNX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for SCNX?

The latest report frames SCNX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the SCNX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.